GCLC and hepatocellular carcinoma: In contrast, recent research has indicated that GSH or NAC supplementation may directly reduce ROS levels and desensitized Nrf2/glutamate-cysteine ligase catalytic subunit (GCLC)-related antioxidant production pathway to promote HCC formation and tumor growth in vitro and in vivo [9].